It ishypothesized that NO signaling could contribute to therapy resistance inepithelial ovarian cancer by modulating survivin expression since low levels ofNO are associated with resistance to carboplatin- and paclitaxel-inducedapoptosis [40]. Here, BIRC5 is linked to ovarian carcinoma.